Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01DIT
|
||||
Former ID |
DNC013700
|
||||
Drug Name |
N-(2-hydroxyethyl)linoleoylamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529848] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H37NO2
|
||||
Canonical SMILES |
CCCCCC=CCC=CCCCCCCCC(=O)NCCO
|
||||
InChI |
1S/C20H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h6-7,9-10,22H,2-5,8,11-19H2,1H3,(H,21,23)/b7-6-,10-9-
|
||||
InChIKey |
KQXDGUVSAAQARU-HZJYTTRNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529848] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.